Antifungal prophylaxis in patients with acute myeloid leukemia research hub

PTX3 genetically stratified randomized double-blinded allocation event-driven clinical trial for antifungal prophylaxis in patients with acute myeloid leukemia

This study looks at different medicines to prevent fungal infections in people with a type of blood cancer called acute myeloid leukaemia. It compares how well these medicines work over 6 months to keep people healthy.